HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1636445Generated: November 1, 2026
Phosgene → 4-Chloro-2-[[5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-2-oxo-1,3,4-oxadiazol-3-yl]methyl]phenyl chloroformate
https://huagongshe.com/reaction/1636445
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Phosgene | HCID 6371 | — |
| Reactant | Bms-191011 | HCID 10474339 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | 4-Chloro-2-[[5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-2-oxo-1,3,4-oxadiazol-3-yl]methyl]phenyl chloroformate | HCID 15462809 | — |
Reaction Steps
A stirred suspension of 3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2(3H)-one (1 g, 2.69 mmol) and BnPh3PCI (25 mg) in 1.9 molar toluene solution of phosgene (15 mL) was heated at 120° C. overnight in a sealed tube. After removal of excess phosgene, the toluene solution was rotary evaporated to dryness to afford the chlorotormate product as a white semi-solid (1.18 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06034113 |
|---|
| Source dataset | uspto-grants-2000_03 |
|---|
| ORD ID | ord-468259b53f214cf7abd8f9422648cb9c |
|---|
| Source note | uspto-grants-2000_03 |
|---|